Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Jun 9;18(11):1649–1655. doi: 10.1016/j.bbmt.2012.05.005

Table 1.

Patient characteristics (N = 290)

Characteristic Data
Case type, N (%)
 Incident 160 (55)
 Prevalent 130 (45)

Patient age at enrollment, median years (range) 51 (2 – 74)

Months from transplant to enrollment, median (range) 12 (3 – 39)

Adults, N (%) 279 (96)

Male, N (%) 169 (58)

Disease status, N (%)
 Early 101 (35)
 Intermediate 127 (44)
 Advanced 62 (21)

Transplant source, N (%)
 Peripheral blood 260 (89)
 Bone marrow 19 (7)
 Cord blood 11 (4)

Transplant type, N (%)
 Myeloablative 162 (56)
 Not-myeloablative 128 (44)

Donor match, N (%)
 HLA-matched related 141 (49)
 HLA-matched unrelated 108 (37)
 HLA-mismatched 41 (14)

Donor and recipient gender, N (%)*
 Female into male 82 (28)
 Other 206 (72)

Prior acute GVHD, N (%) 188 (65)

NIH severity score at enrollment, N (%)
 None 2 (1)
 Mild 37 (13)
 Moderate 167 (57)
 Severe 84 (29)
*

Gender information is not available for 2 donors.